Evaluation of Markers of Inflammation and Oxidative Stress in COPD Patients with or without Cardiovascular Comorbidities.
about
COPD and stroke: are systemic inflammation and oxidative stress the missing links?Circulating biomarkers of oxidative stress in chronic obstructive pulmonary disease: a systematic reviewClassifying oxidative stress by F2-isoprostane levels across human diseases: A meta-analysis.(-)-Epigallocatechin-3-gallate Reduces Cigarette Smoke-Induced Airway Neutrophilic Inflammation and Mucin Hypersecretion in Rats.Decreased activity of butyrylcholinesterase in blood plasma of patients with chronic obstructive pulmonary disease.Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2).
P2860
Evaluation of Markers of Inflammation and Oxidative Stress in COPD Patients with or without Cardiovascular Comorbidities.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Evaluation of Markers of Infla ...... Cardiovascular Comorbidities.
@en
Evaluation of Markers of Infla ...... Cardiovascular Comorbidities.
@nl
type
label
Evaluation of Markers of Infla ...... Cardiovascular Comorbidities.
@en
Evaluation of Markers of Infla ...... Cardiovascular Comorbidities.
@nl
prefLabel
Evaluation of Markers of Infla ...... Cardiovascular Comorbidities.
@en
Evaluation of Markers of Infla ...... Cardiovascular Comorbidities.
@nl
P2093
P1476
Evaluation of Markers of Infla ...... t Cardiovascular Comorbidities
@en
P2093
Adam Antczak
Agnieszka Nielepkowicz-Goździńska
Anna Pękala-Wojciechowska
Maciej Pawłowski
Marcin Kaźmierczak
P304
P356
10.1016/J.HLC.2015.01.019
P577
2015-02-20T00:00:00Z